LAVA Therapeutics N.V. Alternatives & Competitors

12 companies similar to LAVA Therapeutics N.V. — Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibo...

DEM Biopharma, Inc.

Novel Target for Solid Tumors

20 $70.00M

Cambridge, United States

Biotechnology Life Sciences +1

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

121 Acquired $8.43B

Redwood City, United Stat...

Biopharma Biotechnology +3

Qualisure Diagnostics Inc.

Deploying AI-enabled molecular diagnostics globally through decentralized testing and cent...

10 Seed $850.00K

Calgary, Canada

Biotechnology Health Care +1

Focal Medical, Inc. (acquired by Continuity Biosciences)

We are developing novel targeted therapeutic products based on our innovative local drug-d...

4 Series A $12.47M

Cary, United States

Biopharma Biotechnology +1

Rival Readout

Competing with LAVA Therapeutics N.V.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Epitopea

Exploiting a new class of tumour specific antigens for cancer therapy

50 Seed $44.60M

Montreal, Canada

Biotechnology Health and Wellness +1

Crossbow Therapeutics, Inc

Established antibody engineering to target the untapped universe of intracellular cancer t...

45 Series B $157.00M

Cambridge, United States

Biotechnology Health Care +1

Sarcura

Powering New Possibles in Cell Therapy Manufacturing

8 Seed $9.55M

Klosterneuburg, Austria

Biotechnology Life Sciences +1

NextPoint Therapeutics, Inc.

Launching a new world of precision therapeutics through its leading scientific work on th...

38 $122.48M

Biotechnology Health Care +2

Bicycle Therapeutics

Precision-Guided Therapeutics

251 $1.64B

Cambridge, United Kingdom

Biotechnology Health and Wellness +2

Flare Therapeutics

Trailblazing the path to drugging transcription factors to discover precision medicines fo...

62 Series B $205.00M

Cambridge, United States

Biopharma Biotechnology +2

ITM Isotope Technologies Munich SE

Delivering the promise of radiopharmaceuticals to patients.

661 Private Equity

Germany

Biopharma Biotechnology +2

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

258 Acquired $4.78B

San Diego, United States

Biotechnology Health Care +2

About LAVA Therapeutics N.V.

LAVA Therapeutics N.V. is at the forefront of developing groundbreaking cancer treatments through its next-generation bispecific gamma-delta T cell engaging (bsTCE) antibodies. Founded in 2016 and headquartered in The Netherlands, the company specializes in the biotechnology and life sciences industries, with a specifi...

Services

Development of bispecific gamma delta T cell engager therapeutics, Cancer treatment innovation leveraging Gammabody platform, Preclinical and clinical drug candidate development

Target Customers

Cancer patients, Healthcare providers, Biopharmaceutical investors

Business keywords

Gamma-delta T-cell Engagers, Bispecific Antibodies, Immuno-oncology, Cancer Therapy, Vγ9Vδ2 T-cells, Tumor Targeting, LAVA-051, CD1d Antigen, Hematologic Malignancies, Solid Tumors, Preclinical Studies, Immune System Activation, Therapeutics Development, Biopharmaceuticals

Business Model

B2B, B2D, Platform

Revenue Model

Licensing, Performance Based, Service Fee

Frequently Asked Questions

Companies similar to LAVA Therapeutics N.V. include DEM Biopharma, Inc., Arcellx, Qualisure Diagnostics Inc., Focal Medical, Inc. (acquired by Continuity Biosciences), Epitopea. They work in Biotechnology and Life Sciences and share LAVA Therapeutics N.V.'s focus on immuno-oncology, solid tumors and biopharmaceuticals.

Bounce Watch lists 12 companies that share LAVA Therapeutics N.V.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around LAVA Therapeutics N.V.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

LAVA Therapeutics N.V. Profile DEM Biopharma, Inc. Alternatives Arcellx Alternatives Qualisure Diagnostics Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at LAVA Therapeutics N.V. on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.